Story
GSK to Close German Vaccine Plant by 2027, 641 Jobs at Risk
Summary
Pharmaceutical firm GSK has announced the closure of its vaccine manufacturing facility in Dresden, Germany, by summer 2027, a move that threatens 641 jobs as the company pivots to mRNA technology.
Pharmaceutical giant GSK announced on Friday that it will close its vaccine manufacturing facility in Dresden, Germany, by the summer of 2027. The decision places 641 positions at risk, according to the German trade union Industriegewerkschaft Bergbau, Chemie, Energie (IGBCE).
Details of the Closure
Workers at the Dresden site, which currently produces traditional egg-based flu vaccines and hepatitis vaccines, were informed of the plan on Thursday. The closure is part of a strategic shift for the company as it moves away from older manufacturing technologies.
The IGBCE and the plant's works council have both rejected the plans and stated they will oppose the closure. The union warned the move would eliminate highly skilled industrial jobs from the Saxony region and reduce critical pharmaceutical manufacturing capacity in Germany.
AdPivot to mRNA Technology
The plant's closure coincides with GSK's progress in developing next-generation vaccines. The company is reportedly planning to move an mRNA-based seasonal influenza vaccine candidate into late-stage trials this month.
This strategic pivot is supported by promising clinical data. Mid-stage trial results indicated that the new mRNA vaccine generated stronger immune responses than currently approved standard- and high-dose flu shots for both younger and older adults, according to the source.
Read next
More on Stocks
Moore Threads Stock Jumps Over 9% in Rebound From Post-Lockup Sell-Off
Shares of the Chinese GPU maker recovered sharply from multi-month lows as investors looked past a recent technical sell-off and focused on the company's strategic role in China's domestic AI chip market.
Sumitomo Stock Leads Trading Houses Higher on Berkshire Stake Speculation
Shares of Sumitomo Corp. surged on Thursday, leading Japan's major trading houses, following a report that Berkshire Hathaway is considering increasing its investment in the sector.
Weichai Power Shares Surge on Customer's $2.4 Billion AWS Generator Deal
The Chinese engine maker's stock rallied after its U.S. customer, Generac, secured a major contract to supply backup power generators for Amazon's data centers, highlighting strong demand from the AI sector.
Asian Stocks Rise as Fed Hike Eases Bond Market Jitters; China Equities Lag
Most Asian markets advanced after the U.S. Federal Reserve's 25-basis-point rate hike provided policy clarity, calming Treasury yields. However, Chinese and Hong Kong stocks fell, bucking the regional trend.